Clinical Trial Update: Zanubrutinib-based Maintenance Therapy of Newly Diagnosed DLBCL With Initial Remission [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of zanubrutinib-based maintenance therapy in patients with newly diagnosed diffuse Large B-Cell Lymphoma wh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING